Galera Therapeutics Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Galera Therapeutics regular Real Value cannot be determined due to lack of data. The prevalent price of Galera Therapeutics is $0.0. Our model calculates the value of Galera Therapeutics from evaluating the firm fundamentals such as Return On Asset of -0.59, shares owned by insiders of 36.15 %, and Return On Equity of -10.63 as well as inspecting its technical indicators and probability of bankruptcy.
Galera Therapeutics Total Value Analysis
Galera Therapeutics is currently anticipated to have valuation of 146.68 M with market capitalization of 7.89 M, debt of 152.3 M, and cash on hands of 52.01 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Galera Therapeutics fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
146.68 M | 7.89 M | 152.3 M | 52.01 M |
Galera Therapeutics Asset Utilization
One of the ways to look at asset utilization of Galera is to check how much profit was generated for every dollar of assets it reports. Galera Therapeutics retains a negative application of resources of -0.59 (percent), losing $0.005929 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Galera Therapeutics shows how discouraging it operates for each dollar spent on its resources.Galera Therapeutics Ownership Allocation
Galera Therapeutics has a total of 54.39 Million outstanding shares. Galera Therapeutics secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Galera Therapeutics Profitability Analysis
Net Loss for the year was (59.08 M) with profit before overhead, payroll, taxes, and interest of 0.Galera Therapeutics Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 44.5 M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Galera Pink Sheet
If you are still planning to invest in Galera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Galera Therapeutics' history and understand the potential risks before investing.
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |